ID: ALA5268387

Max Phase: Preclinical

Molecular Formula: C17H15Cl2N5

Molecular Weight: 360.25

Associated Items:

Representations

Canonical SMILES:  CCCCn1cnc2c(Cc3ccc(Cl)c(Cl)c3)nc(C#N)nc21

Standard InChI:  InChI=1S/C17H15Cl2N5/c1-2-3-6-24-10-21-16-14(22-15(9-20)23-17(16)24)8-11-4-5-12(18)13(19)7-11/h4-5,7,10H,2-3,6,8H2,1H3

Standard InChI Key:  FWEHGZUJWZBRHV-UHFFFAOYSA-N

Associated Targets(non-human)

Trypanosoma brucei 78846 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.25Molecular Weight (Monoisotopic): 359.0705AlogP: 4.40#Rotatable Bonds: 5
Polar Surface Area: 67.39Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.88CX LogD: 4.88
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.68Np Likeness Score: -1.26

References

1. Rocha DA, Silva EB, Fortes IS, Lopes MS, Ferreira RS, Andrade SF..  (2018)  Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.,  157  [PMID:30282318] [10.1016/j.ejmech.2018.08.079]

Source